Abbott Laboratories (ABT) vs Roche Holding AG (RHHBY)
A side-by-side comparison of Abbott Laboratories and Roche Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.
ABT
Abbott Laboratories
$111.56HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
RHHBY
Roche Holding AG
$56.39HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
Total return — ABT vs RHHBY
growth of $100 · dividends reinvested · last 10yABT +219.0% (+12.3%/yr)RHHBY +158.1% (+9.9%/yr)ABT compounded faster over this window
ABT RHHBY
ABT vs RHHBY: by the numbers
- •RHHBY is the larger company ($359.46B vs $193.04B market cap).
- •RHHBY trades at the lower trailing earnings multiple (16.15 vs 36.69 P/E), one valuation lens rather than an overall verdict.
- •RHHBY converts more revenue to profit (20.33% vs 11.65% net margin).
- •RHHBY grew revenue faster over the past five years (3.94% vs 2.98% CAGR).
- •RHHBY pays the higher dividend yield (2.75% vs 2.17%).
Metrics side by side
Valuation
| Metric | ABT | RHHBY |
|---|---|---|
| P/E ratio | 36.69 | 16.15 |
| Forward P/E | 20.68 | 22.83 |
| P/S ratio | 4.27 | 4.53 |
| P/B ratio | 3.89 | 9.06 |
| EV / EBITDA | 20.79 | 14.21 |
| FCF yield | 4.38% | 4.69% |
Profitability
| Metric | ABT | RHHBY |
|---|---|---|
| Gross margin | 56.80% | 73.73% |
| Operating margin | 17.03% | 29.16% |
| Net margin | 11.65% | 20.33% |
| ROE | 10.61% | 38.06% |
| ROIC | 6.07% | 19.71% |
Dividends
| Metric | ABT | RHHBY |
|---|---|---|
| Dividend yield | 2.17% | 2.75% |
| Payout ratio | 66.31% | 60.81% |
Growth (annualized)
| Metric | ABT | RHHBY |
|---|---|---|
| Revenue CAGR (5Y) | 2.98% | 3.94% |
| EPS CAGR (5Y) | 8.22% | 1.54% |
| FCF CAGR (5Y) | 0.18% | 5.54% |
| Total return CAGR (5Y) | 0.05% | 5.84% |
Frequently asked
- Which has the lower trailing P/E, ABT or RHHBY?
- RHHBY has the lower trailing P/E: ABT trades at 36.69 and RHHBY at 16.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABT or RHHBY?
- Over the past five years, RHHBY grew revenue faster — ABT at a 2.98% CAGR versus RHHBY at 3.94%.
- Does ABT or RHHBY pay a bigger dividend?
- ABT yields 2.17% and RHHBY yields 2.75% based on trailing dividends and the latest price.
- Is ABT or RHHBY more profitable?
- RHHBY runs the higher net margin — ABT at 11.65% versus RHHBY at 20.33%.
- How have ABT and RHHBY total returns compared?
- Over the past 10 years, ABT delivered 12.35% and RHHBY delivered 9.59% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioRoche Holding AG P/E ratioAbbott Laboratories dividend yieldRoche Holding AG dividend yieldAbbott Laboratories ROERoche Holding AG ROEAbbott Laboratories operating marginRoche Holding AG operating marginAbbott Laboratories revenue growthRoche Holding AG revenue growthAbbott Laboratories free cash flowRoche Holding AG free cash flow
Abbott Laboratories & Roche Holding AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.